New Delhi [India], October 13 (ANI): Indian drug maker Dr Reddy's Laboratories (DRL) has submitted a revised application to the Drugs Controller General of India (DCGI) seeking his approval to conduct phase 2 and 3 clinical trials of the Russian COVID-19 vaccine Sputnik V in India, a governm
New Delhi [India], October 13 (ANI): The Central Government has sufficient financial resources available to procure at least 400-500 million doses of COVID-19 vaccine, said Rajesh Bhushan, Union Health Secretary on Tuesday.
Geneva [Switzerland], October 13 (ANI/Sputnik): The World Health Organisation (WHO) believes that safety in research is crucial and is pleased to see developers acting by the rules, the WHO spokesperson told Sputnik regarding Johnson & Johnson suspending its vaccine trials.
New Delhi [India], October 13 (ANI): Group of ministers (GoM), headed by Union Health Minister Dr Harsh Vardhan, met on Tuesday to discuss the current national and international scenario of SARS-CoV2 virus and strategies that are to be adopted for availability and distribution of vaccines
Dhaka [Bangladesh], October 13 (ANI): The clinical trial of an experimental Chinese COVID-19 vaccine developed by Sinovac Biotech in Bangladesh is now uncertain as the health ministry refused to co-financing the initiative as requested by the Chinese drugmaker.
Geneva [Switzerland], October 13 (ANI/Sputnik): The World Health Organization (WHO) believes that a vaccine against the coronavirus disease will be ready for registration by the end of 2020 or early next year at the earliest, Soumya Swaminathan, the WHO chief scientist, said on Monday.
Mexico City [Mexico], October 12 (ANI/Xinhua): Mexico has paid an advance of 159.8 million US dollars to guarantee the purchase of a successful vaccine against the novel coronavirus (COVID-19) through the COVAX initiative, the Mexican foreign ministry reported on Saturday.
New Delhi [India], October 10 (ANI): The expert panel at Central Drugs Standard Control Organisation (CDSCO) has asked drug maker Bharat Biotech to submit safety and immunogenicity data from ongoing phase II trial in order to conduct phase III clinical trial of indigenous COVID-19 vaccine, C
New Delhi [India], October 6 (ANI): In the latest development, the Drugs Controller General of India (DCGI) expert panel has directed the pharma giant Dr Reddy's Laboratories (DRL) to submit a revised protocol for performing phase 2,3 clinical trials of the Russian COVID-19 vaccine (Sputnik
New Delhi [India], October 4 (ANI): The government plans to receive and utilize 40-50 crore Covid-19 vaccine doses to cover 20-25 crore Indians by July 2021, Union Minister of Health and Family Welfare Harsh Vardhan said on Sunday.
New Delhi [India], October 2 (ANI): Indian pharma giant Dr Reddy's Laboratories (DRL) has submitted an application to the Drugs Controller General of India (DCGI) for its approval to perform Phase III clinical trials of the Russian COVID-19 vaccine Sputnik V in India, a government officia
New Delhi [India], September 29 (ANI): Following a tweet by the Serum Institute of India, the Union Health Ministry on Tuesday said it disagrees with the mathematics which asked the government whether it has Rs 80,000 crore to buy and distribute COVID-19 vaccine to everyone in India.